Raltegravir
From Proteopedia
(Difference between revisions)
David Canner (Talk | contribs)
(New page: ===Pharmacokinetics=== {| class="wikitable" border="1" width="52%" style="text-align:center" |- ! colspan="12" align="center"| Retroviral Integrase Inhibitor [[Pharmaceutical_Drugs#Pharma...)
Next diff →
Revision as of 18:22, 6 December 2010
Pharmacokinetics
| Retroviral Integrase Inhibitor Pharmacokinetics [1] | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Parameter | Raltegravir | Elvitegravir | |||||||||
| Tmax (hr) | 1.8 | Elvitegravir | |||||||||
| Cmax (ng/ml) | Raltegravir | 2070 | |||||||||
| Bioavailability (%) | Raltegravir | Elvitegravir | |||||||||
| Protein Binding (%) | Raltegravir | Elvitegravir | |||||||||
| T1/2 (hr) | 7-12 | 7.6 | |||||||||
| AUC (ng/ml/hr) | Raltegravir | 21200 | |||||||||
| Clearance (L/h) | Raltegravir | Elvitegravir | |||||||||
| Dosage (mg) | Raltegravir | 150 | |||||||||
| Metabolism | None | Hepatic - (CYP3A4) | |||||||||
